Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro
The Middle East respiratory syndrome-coronavirus (MERS-CoV), first identified in Saudi Arabia, is an emerging zoonotic pathogen that causes severe acute respiratory illness in humans with a high fatality rate. Since its emergence, MERS-CoV continues to spread to countries outside of the Arabian Peni...
Main Authors: | Jin Soo Shin, Eunhye Jung, Meehyein Kim, Ralph S. Baric, Yun Young Go |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-05-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/10/6/283 |
Similar Items
-
Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib
by: Liwei Lang, et al.
Published: (2018-06-01) -
Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma
by: Liwei Lang, et al.
Published: (2019-12-01) -
«Caractérisation de sept lignées cellulaires humaines de cancer de vessie pour les principaux marqueurs de la transition épithélio-mésenchymateuse, Twist1 et E-cadhérine, et pour une nouvelle drogue, le saracatinib. »
by: Lortal Canguilhem, Barbara
Published: (2012) -
Saracatinib Fails to Reduce Alcohol-Seeking and Consumption in Mice and Human Participants
by: Summer L. Thompson, et al.
Published: (2021-08-01) -
Livestock Susceptibility to Infection with Middle East Respiratory Syndrome Coronavirus
by: Júlia Vergara-Alert, et al.
Published: (2017-02-01)